Background. Recent advances in cell therapies have provided potential opportunities for the treatment of chronic kidney diseases (CKDs). We investigated whether human kidney structures could be preformed in vitro for subsequent implantation in vivo to maximize tissue-forming efficiency. Methods. Human renal cells were isolated from unused donor kidneys. Human renal cells were cultured and expanded. Migration was analyzed using growth factors. To form structures, cells were placed in a three-dimensional culture system. Cells were characterized by immunofluorescence, western blots and fluorescence-activated cell sorting using renal cell-specific markers for podocin, proximal and distal tubules and collecting ducts. An albumin uptake assay was used to analyze function. Three-dimensional cultures were implanted into athymic rat kidneys to evaluate survival. Results. Human renal cells were effectively expanded in culture and retained their phenotype, migration ability and albumin uptake functions. Human renal cell in three-dimensional culture-formed tubules, which stained positively for proximal, distal tubule and collecting duct markers, and this was confirmed by western blot. Polarity of the tubular cells was determined by the presence of Ecadherin, N-cadherin and Na-K ATPase. Colocalization of labeled albumin and proximal tubule markers proved functionality and specificity of the newly formed tubules. An in vivo study showed that cells survived in the kidney for up to 6 weeks.
Introduction
Chronic kidney disease (CKD) has been steadily increasing in the last decade. The National Kidney Foundation estimates that the number of CKD patients will double in the next 10 years [1] . The total Medicare expenditures on patients that progress to end-stage renal disease (ESRD) exceed $17 billion in the USA alone [2, 3] . While dialysis is the most common form of therapy used in patients with ESRD, this modality is only able to prolong survival by partially replacing the filtration function of the kidney. Renal transplantation is the only definitive treatment that can restore complete renal function [4] . However, increasing demand and donor shortage make this treatment challenging.
Recent advances in cell-based therapies have provided potential opportunities to alleviate the current challenges of donor shortage. Many investigative studies have evaluated cell therapy as an alternative treatment modality for acute kidney disease and CKD [5, 6] . Bone marrow mesenchymal stem cells were shown to protect renal function and prevent tissue damage after ischemia reperfusion in animal models of acute renal failure [7] [8] [9] . In animal models of chronic kidney failure, cell therapy with mesenchymal stem cells prevented disease progression [10, 11] . Stem cells derived from human amniotic fluid have demonstrated protective effects in a mouse model of acute tubular necrosis [12] . In addition, organ-specific stem cells and progenitor cells have been described in the kidney [13, 14] . Multipotent progenitor cells have been isolated and characterized from the Bowman's capsule of adult human kidney. When these cells were injected into acute renal failure-induced severe combined immunodeficient mice, signs of improvement in renal function were observed [15] . In another study, embryonic stem cells were seeded in a decellularized rat kidney. These cells interacted with the kidney scaffold and proliferated within the glomerular, vascular and tubular structures, leading to a loss of embryonic cellular characteristics and expression of the markers of differentiated kidney cells [16] .
We previously demonstrated that single renal cells can be isolated from donor tissue, expanded in vitro and reintroduced in vivo for renal tissue regeneration. The potential of renal cell therapy was demonstrated in a study in which culture expanded cells were seeded onto an artificial renal device and implanted in vivo. This resulted in the formation of renal structures that produced urine-like fluid [17] . In this study, single renal cells showed the ability to reconstitute into renal tubules and glomeruli on the artificial renal device. While single renal cells show evidence of reconstitution into functional kidney structures, the efficiency of the process of structural assembly could not be assessed in vivo. A strategy that involves the reconstitution of renal structures during the culture expansion stage was proposed. As such, a three-dimensional culture system that allows for reconstituting single renal cells into kidney structures was developed which provided a controlled platform for renal tissue formation [18] . In this study, we investigated whether human kidney structures could be preformed in vitro for subsequent implantation in vivo to maximize tissue-forming efficiency.
Materials and methods

Preparation of cells
Discarded human kidneys were obtained from Carolina Donor Services after ethical approval by the university institutional review board. Briefly, pieces of the kidney (cortex and medulla) were minced in Krebs buffer until a gel-like consistency was obtained. Liberase blendzyme 3 (Roche, Indianapolis, IN) was added to the tissue. This solution was filtered in a 100-μm filter and centrifuged. The supernatant was re-suspended in complete medium and plated in 15-cm culture dished plates, as described previously [19, 20] . Five different donors were tested. One of the five kidneys had been rejected from the donation pool due to the confirmed diagnosis of arteriosclerosis and glomerulosclerosis.
The medium used for renal cell culture contained one part high glucose Dulbecco's Modified Eagle's Medium (Gibco Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS; Gibco Invitrogen) and 1% penicillin-streptomycin (Gibco Invitrogen) and one part keratinocyte serum-free medium supplemented (Gibco Invitrogen) with 2.5% FBS, 0.02% insulin, transferin and sodium selenite (ITS; SigmaAldrich, St Louis, MO) and 1% penicillin-streptomycin.
Medium was changed every 2 days. Cells were allowed to grow to confluency and then 0.05% trypsin (Gibco Invitrogen) was used to detach cells. After centrifugation, cells were plated at 1:3 ratio.
Characterization of cells
Immunofluorescence and western blot analyses were performed with different antibodies for cell characterization both in two-and three-dimensional cultures. Fluorescence-activated cell sorting (FACS) was performed for cells in two-dimensional culture.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde (Polysciences, Inc., Washington, PA) at room temperature for 10 min. To stain cytoplasmic proteins, the cells were permeabilized with 0.1% Triton (Sigma, St Louis, MO). Primary antibodies were added and incubated for 1 h at room temperature. Secondary antibodies were kept in for 30 min. Control samples for auto fluorescence or non-specific fluorescence were performed on fixed cells or tissue without the primary antibodies. Tissues were paraffin embedded; cut in 4-μm sections and fixed in 10% neutralized buffered formalin. Peroxidase quenching and antigen retrieval were performed prior to staining.
Western blot
Western blot analysis was performed on cell lysates from kidney tissue. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to polyvinylidene fluoride (PVDF) membranes (Bio-Rad, Hercules, CA) and reacted with primary antibodies [neprilysin (NEP) 1:100; erythropoietin (EPO) 1:200; TammHorsfall protein (THP) 1:100; podocin 1 :25] . Membranes were then incubated with the appropriate horseradish peroxidase-conjugated secondary antibody, followed by enhanced chemiluminescence detection to visualize bands. THP, EPO and podocin were purchased from Santa Cruz Biotechnology; Santa Cruz, CA. NEP was purchased from Chemicon-Millipore.
FACS
Primary renal cells at Passage 3 were trypsinized, fixed in 2% paraformaldehyde, permeabilized in 0.1% saponin/phosphate-buffered saline (PBS) buffer and blocked for 30 min in permeabilization buffer containing 3% normal goat serum. Following washes in cold PBS, the cells were re-suspended in blocking buffer at 1.0 × 10 6 cells/mL and incubated with cell-specific unconjugated antibodies to NEP for proximal tubules (sc-19993), epithelial membrane antigen for distal tubules (ab28081; Abcam), THP for distal tubules and collecting ducts (sc-20631), EPO for renal interstitial fibroblasts (sc-1310) and podocin for podocytes (sc-21009). Control cells were labeled with either mouse or rabbit isotype control antibodies (sc-2025 or sc-2027, respectively). All primary antibodies were added at a concentration of 1 μg/mL and were incubated for 30 min at room temperature. After washing 3× with PBS, cells were incubated with Alexa-Fluor 488-conjugated goat anti-rabbit or mouse secondary antibody (Invitrogen) for 15 min at room temperature. Cells were washed 3× with PBS and fixed with 2% paraformaldehyde. A FACSCalibur (Becton-Dickinson, Franklin Lakes, NJ) was used to perform flow cytometry and results were analyzed with FlowJo software (Treestar Inc).
Functional assays
Cell migration. Cell migration assays were performed using the ECM 510 kit from Chemicon. Briefly, 1.5 × 10 4 cells at Passage 3 were kept overnight in serum-free medium, followed by incubation with either human recombinant hepatocyte growth factor (HGF) in different concentrations (5, 10, 60 and 100 ng/mL); 10 −7 M/mL aldosterone, 10% FBS; epidermal growth factor (EGF) in different concentrations (1.25, 2.5 and 5 ng/mL); 0.7% ITS and combinations of 1.25 ng/mL EGF + 60 ng/mL HGF; 2.5 ng/mL EGF + 60 ng/mL HGF + 10 −7 M/mL aldosterone and 5 ng/mL EGF + 60 ng/mL HGF + 10 −7 M/mL aldosterone as chemoattractants. After 4 h, the reaction was stopped and monitored fluorometrically with a FLUOstar OPTIMA microplate reader with excitation at 500 nm and emission at 534 nm. All drugs were purchased from Sigma Albumin uptake. Confluent two dimensional cultures at Passage 3 and three-dimensional cultures were incubated with rhodamine-labeled human albumin (25 µg/mL) (Sigma) at 37°C for 30 min, extensively rinsed (3×) with PBS, fixed for 30 min with 2% paraformaldehyde and subsequently stained for NEP or epithelial membrane antigen (EMA). Viral transfection. Lentiviral transfection was performed using the system devised by Kages and colleagues [21] . In this system, three plasmids were co-transfected into a 293T cell line (ATCC, Houston, TX), resulting in transient expression of virus packaging elements and generation of replication-incompetent Lentiviral vector particles harboring green fluorescence protein (GFP). The virus was added to human renal cells culture and after 24 h, 50% of cells were GFP positive. After 48 h, 100% were GFP positive. Cells were passaged at a ratio of 1:3 and allowed to grow to confluency to confirm the transfection rate.
Three-dimensional cultures. Rat tail collagen Type I (BD Falcon, San Jose, CA), and 199× Media (Gibco Invitrogen) were mixed in a ratio of 9:1 and the pH was adjusted to 7.4 using 1× NaOH (Sigma). Cells at Passage 3 were suspended at a concentration of 12 × 10 6 cells/mL and added to the collagen as previously described [22] . The cell-matrix suspension at a volume of 150 µL was placed in 48-well tissue culture plates. The plate was kept in a 37°C incubator at 5% CO 2 for 20 min allowing collagen solidification to allow a gelatin-like consistency for the scaffolds. After solidification, medium was added to each well and changed every 2 days for the 10-day culture period.
In vivo study. Experiments were performed using adult athymic male rats (Harlan Laboratories). Animals were used according to protocols approved by the Wake Forest University Institutional Animal and Care and Use Committee. Under isoflurane anesthesia, animals underwent a nephrotomy in the right kidney and the three-dimensional culture (collagen Reconstruction of human kidneyscaffold with cells) was implanted within the kidney parenchyma. Suture was performed in order to keep the scaffold in the kidney parenchyma. The same procedure was performed in the left kidney with implantation of a collagen scaffold without cells. Animals were euthanized at three different time points: 1, 3 and 6 weeks post-implant.
Results
Cell culture
Cells from discarded human kidneys (age range, 2 months to 69 years) with no known morbidities were harvested as a heterogenous population using the same methods described by our group for rodent renal cell harvest [18, 19] . All procedures were approved by the Institutional Review Board of Wake Forest University. Under phase contrast microscopy, different cell morphologies (data not shown) were visualized over multiple passages. Growth curves were analyzed from five different donors, and these showed that in 3 days, the cells doubled their number. Cells were cultivated on average for 50.8 ± 15.8 days and the population doubling in this period was 18.52 ± 1.66 times. In 45 days, independently of the donors' age or kidney morphology, the cell population doubled 18 times, showing the in vitro ability of expansion of human kidney cells (Figure 1 ).
Characterization of two-dimensional cell cultures
In order to determine which cell types were grown in the heterogenous culture, immunofluorescence and western blot analyses were performed. Markers for proximal tubule (anti-NEP), distal tubule (EMA), collecting duct (THP), podocytes ( podocin-PODO) and EPO-producing fibroblasts (EPO) were tested for the first three passages. Immunofluorescence labeling showed specific staining in all passages. Cells expressing the same markers tended to cluster in groups distinct from other cell types in the culture plate (Figure 2 ).
In agreement with the immunofluorescence, the western blot analysis was positive for the same proteins ( Figure 3 ). Western blot analysis using EPO antibody showed a double band at 35 kDa in all passages. Human kidney tissue and Knrk (normal rat kidney cells lysate) were used as positive controls. Western blots for NEP, THP and podocin (86, 50 and 53 kDA, respectively) showed positive results in all test passages and the corresponding positive controls. Together, the data show that human kidney cells harvested as a heterogenous population kept their phenotype in two-dimensional cultures over three passages.
To determine the number of specific cells present in Passage 3, FACS was performed. EPO-positive cells were the most prevalent ones (54%). The second most prevalent was podocin (36.6%). Other markers studied included: THP (33.2%), EMA (23%) and NEP 2.53%. These findings confirm the existence of subtypes of cells in the primary culture.
Migration assay
A migration assay was performed to determine if this heterogenous cell population, at Passage 3, maintained the ability to migrate toward growth factor signals. The assay showed that 30% of cells migrate within 4 h toward all the growth factors tested. However, no significant differences among the different growth factors and dosages were found.
Functional assay
To evaluate the function of cells in vitro, human recombinant albumin labeled with rhodamine was added to cells growing in a monolayer on a 0.4-μm membrane. Albumin was added to the apical side of cells and after 30 min, the labeled albumin was visualized in the cytoplasm of some cells ( Figure 4A ). Labeled albumin was not visualized in the basolateral side of the insert. Staining for NEP ( proximal tubule) and EMA (distal tubule) showed albumin uptake for the proximal tubule cells but not for the distal tubule cells ( Figure 4B and C, respectively).
Three-dimensional cell culture
Three-dimensional culturing methods were used to allow epithelial renal cells to undergo tubulogenesis. After 10 days in the three-dimensional culture, tubule-like structures were formed. Hematoxylin and eosin staining showed cystic structures, some showing a small degree of extension resembling branching morphogenesis.
To obtain enhanced visualization of these structures, immunofluorescence for the different tubule markers was analyzed with confocal microscopy. Confocal images showed rounded and elongated structures with internal lumen. Lentivirus GFP-transfected cells showed elongated structures with lumen, tubule-like structures and also some cystic structures ( Figure 5 ). These structures in the three-dimensional collagen culture stained positive for markers of proximal tubule (NEP), distal tubule (EMA), collecting duct (Tamm-Horsfall) and EPO. Cells forming a single structure were only positive for a single tubule marker. Proximal and distal cells were never observed together in the same structure. Podocin antibody was not positive in any of the three-dimensional culture experiments.
Western blot analyses confirmed the results of the immunostaining. EPO, NEP and THP were positive in the three-dimensional culture. E-cadherin, N-cadherin and Na/K ATPase pumps were all located at the proper locations in the cells. These results indicate that during the tubulogenesis process in the three-dimensional culture, epithelial tubular cells migrated and formed tubule-like structures with adequate polarization. These data suggest that three-dimensional culture is an excellent tool for studying tubulogenesis, as it not only induces formation of tubule-like structures but also maintains the cell phenotypes ( Figure 6 ).
Functionality assays
Human recombinant albumin labeled with rodhamine was added to the three-dimensional cultures. After 30 min, albumin was taken up by the cells (Figure 7) . To identify the type of cells incorporating albumin, immunostains with anti-NEP and anti-EMA were performed. Proximal tubular cells were the only ones that uptook the albumin ( Figure 7B ). Thus, along with phenotype and the ability to migrate and form tubule-like structures, these cells and newly formed tubules kept the specialized function of protein uptake.
In vivo study
Lentivirus GFP-transfected cells were allowed to grow into collagen scaffolds. Scaffolds with or without cells were surgically implanted in athymic rats. Animals were followed for 1, 3 and 6 weeks. At these time points, animals were euthanized under anesthesia and kidneys were harvested. We analyzed the survival and integration of these human cells in vivo. After 1 week, cells were found and located close to the implantation site. Moreover, some tubule-like structures could be seen in the tissue. After the first week time point, some cells migrated out of the collagen and integrated into the glomerular and in the interstitial space near veins and arteries. No tumorogenicity was observed in the experiments. Human von Willebrand factor positive cells were also seen (Figure 8 ).
Discussion
The concept of cell-based approaches has been proposed as a method to improve, restore or replace renal function [23, 24] . In this study, we demonstrate that human renal cells can be expanded in vitro while maintaining their phenotype and function. In a three-dimensional culture system, these cells generate kidney structures. Human renal cells demonstrate the capability of cyst formation with internal lumen as well as formation of tubule-like structures with proper polarization and selective uptake of albumin. When exposed to an in vivo environment, the cells survived and migrated to glomerular and interstitial areas. This in vitro study may be a model for future studies of molecular mechanisms of human kidney epithelial cells.
In this study, a primary heterogeneous population of cells harvested from discarded human kidneys was expanded for up to 18 population doublings in a two-dimensional culture. These cells were characterized for expression of markers of renal differentiated epithelial cells such as NEP, THP and EMA using immunostaining, western blot assay and FACS up to the third passage. Markers suggesting the presence of podocytes and EPOproducing cells were also present in all tested cells, suggesting the presence and expansion of those types of cells as well. These data suggest that two-dimensional culture can be used for expanding human renal cells and, more interestingly, that their phenotype is maintained throughout this process.
The 'in vitro' study was conducted on five different kidneys from donors of different ages and genders. Of the five donors, a 60-year-old female had a serum creatinine level over 2.5 mg/dL at hospital admission. This patient's kidney was discarded from the donation pool due to a confirmed diagnosis of glomerulosclerosis. Nevertheless, the cells derived from this kidney were able to grow and maintain phenotype and function similar to those obtained Reconstruction of human kidneyfrom other donors. Therefore, we may assume that expanding renal autologous cells from CKD patients may be a feasible approach.
Cell migration plays a basic role in many physiological and pathophysiological processes such as embryogenesis, immune defense, wound healing and metastasis. This process requires the directed reorganization of the cytoskeleton [25] the activity of ion channels and transporters [26] [27] [28] [29] [30] and coordinated formation of focal adhesion contacts to the extracellular matrix [31] . Results from our migration assay showed that human renal cells expanded in culture kept their ability to coordinate all this machinery and migrate toward different growth factors such as HGF, EGF and aldosterone, which are the same growth factors that coordinate the kidney embryogenesis [32] [33] [34] [35] .
Epithelial cells grown in monolayers are frequently used as a model for epithelial polarity [36, 37] . Using this methodology in combination with the use of human recombinant rhodamine-labeled albumin, we demonstrated that human renal cells are able to uptake albumin. Proximal tubular cells marked with anti-NEP took up this albumin, while distal tubular cells labeled with anti-EMA were exposed to albumin and did not uptake the protein [38] .
Once the phenotype and migration capability were demonstrated in two-dimensional culture, these cells were cultured in a collagen Type I matrix, with addition of growth factors such as HGF, EGF and ITS. Ten days in this culture system allowed cells to form rounded structures with an internal lumen, tight junctions and extensions similar to the ones in embryonic development and also tubule-like structures. These experiments were performed with cells from all donors, and the same findings were seen among all of them. Therefore, we may presume that independently of age and gender, human renal cells are potentially able to form cysts and tubulelike structures when exposed to a favorable environment.
Epithelial morphogenesis is a highly complex multistep process that requires coordinated cell-to-cell and cell-toextracellular matrix interactions as well as time to create three-dimensional structures [39] [40] [41] . In this study, this technology was used in human cells from different ages to examine the ability of the cells to undergo tubule formation. Cells from different tubular segments were able to group together and form polarized functional tubules in vitro. In addition, these three-dimensional culture systems may provide an exceptional in vitro model for the study of cell signaling and cell-matrix interactions.
In the three-dimensional system, cell-to-cell and cellmatrix interactions allowed the formation of tubule-like structures that expressed tubular epithelial markers in immunostains and western blot assays. These cells could form differentiated tubule-like structures. However, it was quite clear that proximal and distal tubular cells did not coexist in the same structure, emphasizing their ability to identify each other. Podocytes were not able to survive in this environment. This result was not unexpected since this particular type of cell presents a low proliferation rate and demands special culture conditions [42] .
Albuminuria is an important indicator and possible pathogenic factor in CKD progression. Reabsorption of albumin from the glomerular filtrate is made via receptormediated endocytosis in the proximal tubule in the normal kidney [43] . In this three-dimensional culture system, tubule-like structures formed by human renal cells selectively absorbed albumin. Distal cells stained for EMA did not take up albumin. Meanwhile, single cells and tubule-like structures expressing NEP growing in the collagen exhibited rhodamine-labeled albumin in their cytoplasm. This structure formation system has great potential for therapeutic uses particularly when combined with collagen since collagen is Food and Drug Administration (FDA) approved.
In order to evaluate the potential cell therapy use of these in vitro grown cells, the three-dimensional cultured cells were implanted into athymic rat kidneys. To identify these human cells inside the rat kidney, cells were transfected with GFP lentivirus and further stained for GFP. Cells transfected with GFP lentivirus cultured in three-dimensional conditions formed the same structures. These scaffolds were implanted in athymic rats as a controlled environment for tracking these human cells. After 1 week, the collagen scaffold could be easily visualized and cells were stained with an anti-GFP antibody. Tubule-like structures and single cells were identified in the collagen area. In the interface between collagen and normal parenchyma, human cells could also be visualized. After 3 weeks, these cells were out of the scaffold and integrated either in the glomerular or in the interstitial areas. These results were quite promising showing that human renal cells implanted in vivo were able to migrate and integrate into existing renal structures.
In conclusion, human renal cells can be harvested from normal and diseased tissue and grown in culture while maintaining phenotype and function. When exposed to extracellular matrix, these cells formed tubule-like structures with proper polarization and function. Collagen scaffolds implanted in vivo allowed cells to survive and migrate toward the parenchyma and integrate into glomerular and interstitial structures. Therefore, this model could be an important tool for studies in the physiology of human renal cells with probable implications in future clinical therapies.
